A MULTI-FUNCTIONAL PRINTER
    1.
    发明申请
    A MULTI-FUNCTIONAL PRINTER 审中-公开
    多功能打印机

    公开(公告)号:WO0029218A3

    公开(公告)日:2000-08-31

    申请号:PCT/GB9903544

    申请日:1999-10-26

    CPC classification number: B41J3/407 B41J3/36 B41J3/39

    Abstract: The invention relates to a printer comprising a scanning means provided in a housing, the scanning means arranged to move within the housing; mounting means for releasably mounting a printhead to the scanning means; an aperture provided within the housing, the aperture arranged to be placed on, or adjacent to, an image receiving medium such that the printhead, when mounted, is operable to print onto the image receiving medium through the aperture. In order to engrave an image into the image receiving medium it is proposed that the mounting means is arranged to accommodate a holding means which holds a machining device for machining a medium. Further, it is proposed that the printer is provided with an ink supply containing a security ink, especially for printing entry receipts onto the hand of a customer entering a discotheque or concert.

    Abstract translation: 本发明涉及一种包括设置在壳体中的扫描装置的打印机,该扫描装置设置成在壳体内移动; 用于将打印头可释放地安装到扫描装置的安装装置; 设置在壳体内的孔,孔被布置成放置在图像接收介质上或邻近图像接收介质,使得当安装时打印头可操作以通过孔打印到图像接收介质上。 为了将图像雕刻到图像接收介质中,建议安装装置设置成容纳保持用于加工介质的加工装置的保持装置。 此外,建议打印机设置有包含安全墨水的墨水供应源,特别是用于将进入的收据打印到进入迪斯科舞厅或音乐会的客户的手上。

    H2 ANTAGONIST-GASTROINTESTINAL MOTILITY AGENT COMBINATIONS
    2.
    发明申请
    H2 ANTAGONIST-GASTROINTESTINAL MOTILITY AGENT COMBINATIONS 审中-公开
    H2拮抗剂 - 胃肠动力学药剂组合

    公开(公告)号:WO1995001803A1

    公开(公告)日:1995-01-19

    申请号:PCT/US1994007520

    申请日:1994-07-05

    Abstract: This invention relates to pharmaceutical compositions for use in the prevention, treatment and relief of indigestion, sour stomach, heartburn, gastroesophageal reflux, dyspepsia, constipation, over-indulgence and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising: (i) an amount effective in the relief of gastrointestinal or esophagus disorders of an H2 antagonist selected from a compound of formula (I) and pharmaceutically acceptable salts, hydrates, stereoisomers or polymorphs thereof, and (ii) an amount effective in the relief of gastrointestinal or esophagus disorders and in the promotion of gastric emptying of a gastrointestinal motility agent such as cisapride, and optionally (iii) an amount effective in the relief of flatulence of simethicone or alpha-D-galactosidase.

    Abstract translation: 本发明涉及用于通过施用组合物来预防,治疗和缓解消化不良,酸胃,胃灼热,胃食管反流,消化不良,便秘,过度放纵和其它胃肠疾病的药物组合物,所述组合物包含:(i )有效减轻选自式(I)化合物和其药学上可接受的盐,水合物,立体异构体或多晶型物的H 2拮抗剂的胃肠道或食道疾病的量,和(ii)有效缓解胃肠道或 食道障碍和促进消化肠蠕动剂如西沙必利的胃排空,以及任选地(iii)有效减轻二甲硅油或α-D-半乳糖苷酶肠胃气胀的量。

    H2 ANTAGONIST-ALGINATE-ANTACID COMBINATIONS
    3.
    发明申请
    H2 ANTAGONIST-ALGINATE-ANTACID COMBINATIONS 审中-公开
    H2拮抗剂 - 氨基酸 - 抗坏血酸组合

    公开(公告)号:WO1995001795A1

    公开(公告)日:1995-01-19

    申请号:PCT/US1994007519

    申请日:1994-07-05

    Abstract: This invention relates to pharmaceutical compositions for use in the treatment and relief of indigestion, sour stomach, heartburn and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising: (i) an amount effective in the relief of gastrointestinal or esophagus disorders of an H2 antagonist selected from a compound of formula (I) and its pharmaceutically acceptable salts, hydrates, stereoisomers or polymorphs and (ii) an amount effective in relief of gastrointestinal or esophagus disorders of at least one of the alginates and (iii) an amount effective in relief of gastrointestinal distress of an antacid wherein the antacid provides a buffering effect and generates carbon dioxide to aerate the alginate.

    Abstract translation: 本发明涉及用于治疗和缓解哺乳动物(包括人)中的消化不良,胃酸,胃灼热和其它胃肠疾病的药物组合物,其包括:(i)有效缓解胃肠道或食管疾病的量 选自式(I)化合物及其药学上可接受的盐,水合物,立体异构体或多晶型物的H2拮抗剂和(ii)有效缓解至少一种藻酸盐的胃肠道或食道疾病的量,和(iii) 有效地缓解了抗酸剂的胃肠窘迫,其中抗酸剂提供缓冲效果并产生二氧化碳以使藻酸盐充气。

    H2 ANTAGONIST-ALGINATE COMBINATIONS
    4.
    发明申请
    H2 ANTAGONIST-ALGINATE COMBINATIONS 审中-公开
    H2拮抗剂 - ALGINATE组合

    公开(公告)号:WO1995001780A1

    公开(公告)日:1995-01-19

    申请号:PCT/US1994007521

    申请日:1994-07-05

    CPC classification number: A61K31/80 A61K31/715 A61K31/425 A61K2300/00

    Abstract: This invention relates to pharmaceutical compositions for use in the treatment and relief of indigestion, sour stomach, heartburn and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising: (i) an amount effective in the relief of gastrointestinal or esophagus disorders of an H2 antagonist selected from a compound of formula (I) and its pharmaceutically acceptable salts, hydrates, stereoisomers or polymorphs and (ii) an amount effective in relief of gastrointestinal or esophagus disorders of at least one of the alginates and optionally (iii) an anti-flatulent amount of simethicone.

    Abstract translation: 本发明涉及用于治疗和缓解哺乳动物(包括人)中的消化不良,胃酸,胃灼热和其它胃肠疾病的药物组合物,其包括:(i)有效缓解胃肠道或食管疾病的量 选自式(I)化合物及其药学上可接受的盐,水合物,立体异构体或多晶型物的H2拮抗剂和(ii)有效缓解至少一种藻酸盐的胃肠道或食道疾病的量和任选地(iii) 抗脓性量的二甲硅油。

    IBUPROFEN-H2 ANTAGONIST COMBINATIONS
    5.
    发明申请
    IBUPROFEN-H2 ANTAGONIST COMBINATIONS 审中-公开
    IBUPROFEN-H2拮抗剂组合

    公开(公告)号:WO1994007541A1

    公开(公告)日:1994-04-14

    申请号:PCT/US1993008947

    申请日:1993-09-21

    Abstract: This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and in the relief of indigestion, sour stomach, heartburn and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising (i) an analgesically and anti-inflammatory effective amount of a salt of (S)-ibuprofen substantially free of (R)-ibuprofen wherein the salt is selected from (S)-ibuprofen-(S)-lysine and (S)-ibuprofen-(R)-lysine; and (ii) an amount effective in the relief of indigestion, sour stomach, heartburn, overindulgence and other gastrointestinal disorders of at least one of the H2 antagonists.

    Abstract translation: 本发明涉及用于治疗疼痛和炎症以及通过施用组合物来减轻哺乳动物(包括人)中的消化不良,酸胃,胃灼热和其它胃肠道疾病的药物组合物,其包含(i)止痛和消炎有效 (S) - 布洛芬的盐的量基本上不含(R) - 布洛芬,其中盐选自(S) - 布洛芬 - (S) - 赖氨酸和(S) - 布洛芬 - (R) - 赖氨酸; 和(ii)有效减轻至少一种H2拮抗剂的消化不良,胃酸,胃灼热,过度抑制和其它胃肠道疾病的量。

    IBUPROFEN-DECONGESTANT COMBINATIONS
    6.
    发明申请
    IBUPROFEN-DECONGESTANT COMBINATIONS 审中-公开
    IBUPROFEN-DECONGESTANT组合

    公开(公告)号:WO1992017171A1

    公开(公告)日:1992-10-15

    申请号:PCT/US1992002388

    申请日:1992-03-24

    Abstract: This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and the relief of nasal congestion and sinus pressure in a mammalian organism, said composition comprising: (i) an analgesically and anti-inflammatory effective amount of (S)-ibuprofen, or a salt thereof, substantially free of (R)-ibuprofen; and (ii) a sympathomimetically effective amount of at least one of the sympathomimetic amines selected from phenylephrine, phenylpropanolamine, pseudoephedrine, oxymetazoline, ephinephrine, naphazoline, xylometazoline, propylhexedrine, levo-desoxyephedrine or a therapeutically active stereoisomer thereof substantially free of its other stereoisomers or a pharmaceutically acceptable salt thereof.

    Abstract translation: 本发明涉及用于治疗疼痛和炎症以及减轻哺乳动物生物体中鼻充血和窦压力的药物组合物,所述组合物包含:(i)止痛和消炎有效量的(S) - 布洛芬 ,或其盐,基本上不含(R) - 布洛芬; 选自去氧肾上腺素,苯丙醇胺,伪麻黄碱,羟甲唑啉,肾上腺素,萘甲唑啉,甲氧唑啉,丙基己烯醛,左旋脱氧麻黄碱或其基本上不含其它立体异构体的治疗活性立体异构体的至少一种拟交感神经胺, 其药学上可接受的盐。

    IBUPROFEN-DIURETIC COMBINATIONS
    7.
    发明申请
    IBUPROFEN-DIURETIC COMBINATIONS 审中-公开
    IBUPROFEN-DIURETIC组合

    公开(公告)号:WO1992005786A1

    公开(公告)日:1992-04-16

    申请号:PCT/US1991007008

    申请日:1991-09-25

    Abstract: This invention relates to a pharmaceutical composition for use in the relief of pain, cramps, bloating and tension experienced during menstruation or premenstruation in a female in need of such relief comprising administering to such female: (i) an analgesically and anti-inflammatory effective amount of (S)-ibuprofen, or a salt thereof, substantially free of (R)-ibuprofen; and (ii) a diuretically effective amount of a diuretic; and (iii) optionally a tension relieving effective amount of pyrilamine maleate.

    Abstract translation: 本发明涉及一种药物组合物,其用于缓解在需要这种缓解的女性中经期或月经前经历的疼痛,痉挛,腹胀和张力,包括给予这种女性:(i)止痛和消炎有效量 的(S) - 布洛芬或其盐,基本上不含(R) - 布洛芬; 和(ii)利尿剂的利尿剂有效量; 和(iii)任选地缓释有效量的马来酸吡拉咪胺。

    MEDIA LIBRARY MONITORING SYSTEM AND METHOD
    9.
    发明申请
    MEDIA LIBRARY MONITORING SYSTEM AND METHOD 审中-公开
    媒体图书监控系统及方法

    公开(公告)号:WO2009099885A1

    公开(公告)日:2009-08-13

    申请号:PCT/US2009/032402

    申请日:2009-01-29

    Inventor: SIMS, Robert, C.

    CPC classification number: G06F11/30

    Abstract: Embodiments of methods and systems comprise collecting data associated with a library or library components and storing the collected data in repository. By collecting data associated with a library or library components and storing the collected data in a repository, the degradation of library components can be monitored and the reliability of library components determined, allowing unreliable components to be bypassed or replaced, enhancing the reliability of the library and preventing data loss.

    Abstract translation: 方法和系统的实施例包括收集与库或库组件相关联的数据并将收集的数据存储在存储库中。 通过收集与库或库组件相关联的数据并将收集的数据存储在存储库中,可以监视库组件的劣化,并确定库组件的可靠性,允许忽略或替换不可靠组件,增强库的可靠性 并防止数据丢失。

Patent Agency Ranking